HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas A Buchholz Selected Research

Mastectomy (Mammectomy)

11/2017A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.
11/2017Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy.
1/2017Cost and Complications of Local Therapies for Early-Stage Breast Cancer.
1/2017Postoperative Radiation Therapy after Nipple-Sparing or Skin-Sparing Mastectomy: A Survey of European, North American, and South American Practices.
2/2016Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis.
9/2015Utilization and Outcomes of Breast Brachytherapy in Younger Women.
6/2014Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
3/2014Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.
2/2014Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.
1/2014Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas A Buchholz Research Topics

Disease

189Breast Neoplasms (Breast Cancer)
10/2021 - 01/2002
122Neoplasms (Cancer)
10/2021 - 01/2002
17Inflammatory Breast Neoplasms
11/2019 - 01/2002
16Neoplasm Metastasis (Metastasis)
01/2019 - 08/2002
11Noninfiltrating Intraductal Carcinoma (DCIS)
02/2016 - 11/2002
10Pathologic Complete Response
04/2016 - 06/2005
5Lung Neoplasms (Lung Cancer)
07/2015 - 09/2011
5Margins of Excision
05/2014 - 02/2003
5Carcinoma (Carcinomatosis)
04/2009 - 10/2003
4Death (Near-Death Experience)
06/2015 - 03/2005
4Ductal Carcinoma
10/2007 - 01/2005
3Lobular Carcinoma
07/2018 - 01/2005
3Melanoma (Melanoma, Malignant)
10/2016 - 05/2014
3Brain Neoplasms (Brain Tumor)
01/2016 - 07/2010
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2014 - 11/2008
3Fat Necrosis
02/2014 - 07/2002
2Obesity
10/2021 - 10/2012
2Fibrosis (Cirrhosis)
12/2018 - 07/2002
2Squamous Cell Carcinoma of Head and Neck
11/2016 - 01/2015
2Lymphatic Metastasis
04/2016 - 04/2009
2Esophageal Neoplasms (Esophageal Cancer)
03/2016 - 06/2009
2Infections
02/2016 - 02/2014
2Prostatic Neoplasms (Prostate Cancer)
07/2014 - 09/2011
2Triple Negative Breast Neoplasms
07/2014 - 03/2012
2Mastodynia
02/2014 - 05/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2014 - 11/2013
2Heart Failure
11/2013 - 06/2005
2Sarcoma (Soft Tissue Sarcoma)
10/2012 - 11/2005
2Rib Fractures (Rib Fracture)
05/2012 - 07/2002
2Unilateral Breast Neoplasms
02/2012 - 11/2008
2Renal Cell Carcinoma (Grawitz Tumor)
04/2011 - 04/2011
2Hypothyroidism
08/2009 - 03/2008
2Stroke (Strokes)
11/2008 - 06/2006
2Pneumonia (Pneumonitis)
11/2004 - 07/2002
2Ataxia Telangiectasia (Louis Bar Syndrome)
09/2004 - 04/2004
1Breast Cancer Lymphedema
01/2019
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
12/2018
1Residual Neoplasm
04/2017

Drug/Important Bio-Agent (IBA)

22Estrogen ReceptorsIBA
01/2020 - 10/2003
18Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 06/2002
16Hormones (Hormone)IBA
10/2019 - 01/2005
11Biological ProductsIBA
02/2014 - 09/2004
9TamoxifenFDA LinkGeneric
01/2020 - 01/2002
9human ERBB2 proteinIBA
04/2017 - 06/2005
9Proteins (Proteins, Gene)FDA Link
02/2014 - 09/2004
9Trastuzumab (Herceptin)FDA Link
11/2013 - 06/2005
8Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 04/2002
8Estrogens (Estrogen)FDA Link
12/2013 - 04/2002
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2011 - 06/2002
7AnthracyclinesIBA
01/2012 - 06/2002
7Fluorouracil (Carac)FDA LinkGeneric
07/2011 - 06/2002
6ErbB Receptors (EGF Receptor)IBA
01/2015 - 06/2005
6Paclitaxel (Taxol)FDA LinkGeneric
07/2011 - 03/2003
5Biomarkers (Surrogate Marker)IBA
01/2016 - 06/2002
3Aromatase InhibitorsIBA
10/2016 - 08/2010
3DNA (Deoxyribonucleic Acid)IBA
03/2011 - 02/2004
3NF-kappa B (NF-kB)IBA
12/2010 - 11/2003
3Transcription Factors (Transcription Factor)IBA
12/2010 - 11/2003
3Docetaxel (Taxotere)FDA Link
12/2008 - 01/2003
3Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2Valproic Acid (Depakote)FDA LinkGeneric
11/2015 - 11/2012
2MicroRNAs (MicroRNA)IBA
04/2015 - 07/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2014 - 02/2014
2ProgesteroneFDA LinkGeneric
12/2013 - 12/2011
2Dihydrotachysterol (AT 10)IBA
10/2012 - 10/2005
2Messenger RNA (mRNA)IBA
05/2012 - 06/2005
2taxaneIBA
07/2011 - 11/2004
2Sunitinib (Sutent)FDA Link
04/2011 - 04/2011
24-azidobenzylcarazolol (pABC)IBA
03/2009 - 01/2002
2Pharmaceutical PreparationsIBA
12/2008 - 06/2005
2Taxoids (Taxanes)IBA
12/2008 - 10/2008
2Hematoxylin (Haematoxylon)IBA
11/2005 - 04/2005
2Eosine Yellowish-(YS) (Eosin)IBA
11/2005 - 04/2005
2Complementary DNA (cDNA)IBA
04/2004 - 03/2003
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2018
1Capecitabine (Xeloda)FDA Link
11/2017
1MK-8776IBA
11/2016
1Checkpoint Kinase 1IBA
11/2016
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2016

Therapy/Procedure

111Radiotherapy
10/2021 - 01/2002
57Therapeutics
10/2021 - 04/2002
52Drug Therapy (Chemotherapy)
10/2021 - 01/2002
47Mastectomy (Mammectomy)
11/2017 - 01/2002
41Neoadjuvant Therapy
01/2019 - 01/2002
40Segmental Mastectomy (Lumpectomy)
10/2021 - 07/2002
9Adjuvant Chemotherapy
07/2017 - 07/2002
8Mammaplasty (Breast Reconstruction)
02/2016 - 10/2002
7Aftercare (After-Treatment)
01/2017 - 11/2002
6Adjuvant Radiotherapy
07/2012 - 03/2005
5Lymph Node Excision (Lymph Node Dissection)
01/2019 - 09/2010
5Brachytherapy
01/2017 - 01/2011
3Hospice Care (Care, Bereavement)
06/2015 - 01/2014
3Simple Mastectomy
01/2009 - 03/2004
2Contraindications
10/2018 - 01/2006
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2016 - 11/2013
2Salvage Therapy
10/2013 - 11/2002
2Chemoprevention
01/2006 - 11/2002
1Duration of Therapy
10/2019
1Patient Positioning
01/2019
1Immunotherapy
10/2016